Year: 2022

Reference is made to the stock exchange announcement by Awilco Drilling PLC (the “Company”) published on 21 December 2022, regarding the successful private placement of new Sponsored Norwegian Depository Receipts in the Company (the “Private Placement”). Certain of the Company’s primary insiders and their close associates have subscribed and been allocated new Sponsored Norwegian Depository Receipts in the Private Placement as further described in the attached forms. Aberdeen, 24 December 2022   For further information please contact: Erik Jacobs, CEO of Awilco Drilling; Tel: +44 1224 737900Cathrine Haavind, Investor Relations of Awilco Drilling; Tel: +47 93 42 84 64, ch@awilcodrilling.com This information is subject to the disclosure requirements in Article 19 of MAR (Regulation (EU) No. 596/2014 on market...

– FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA – – Coherus and Junshi Biosciences are actively engaged in ongoing discussions with the FDA to support the inspections and gain approval of toripalimab for patients with NPC in the U.S. as quickly as possible – SHANGHAI, China, and REDWOOD CITY, Calif., Dec. 24, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced that the companies have not received an action letter from the U.S. Food and Drug Administration (FDA, the Agency) regarding the Biologics License Application (BLA) for toripalimab in combination with chemotherapy as treatment for recurrent or metastatic...

VANCOUVER, British Columbia, Dec. 23, 2022 (GLOBE NEWSWIRE) — PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company“), the digital face of the plant-based community, operating a one-stop shop for plant-based products, announces the filing of its restated audited consolidated comparative financial statements and accompanying management’s discussion and analysis for the year ended March 31, 2021 (the “Restated Financial Statements“) and the filing of its annual financial statements for the year ended March 31, 2022 along with its associated management’s discussion and analysis and related officer certifications (the “Annual Filings“). The Restated Financial Statements and the Annual Filings are available under the Company’s SEDAR profile at www.sedar.com. Highlights...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 23, 2022 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; FRA:4NC), a healthcare technology and services company, today announced a secured convertible note financing in the amount of CAN $1.2 million, which includes a CAN $200,000 original issue discount (“OID”). CAN $1.2 Million Secured Convertible Note This investment will be in the form of a secured convertible note (the “Note”) with a face value of CAN $1.4 million, for aggregate gross proceeds to the Company of CAN $1.2 million after deduction of the OID. Cumulative interest on the outstanding principal amount shall be payable at the annual rate of 8.0% per annum. The Note is expected to mature on December 31, 2023 and will be convertible,...

HOLLAND LANDING, Ontario, Dec. 23, 2022 (GLOBE NEWSWIRE) — Inscape Corporation (“Inscape” or the “Company”) (TSX: INQ), and HUK 121 Limited (the “Offeror”), a subsidiary of Hilco Capital Limited (“Hilco”), are pleased to jointly announce that the Offeror has been successful in its bid to purchase common shares (the “Common Shares”) of Inscape as previously disclosed on October 29, 2022 (the “Offer”). Each of the conditions to the Offer was satisfied or waived by 5:00 p.m. (Toronto time) on December 23, 2022 (the “Initial Expiry Time”). At the Initial Expiry Time, 12,661,625 Common Shares (representing approximately 88.05% of the issued and outstanding Common Shares) (the “Deposited Shares”) were deposited to the Offer and have now been taken up by the Offeror. The aggregate consideration payable for the Deposited Shares is approximately...

MISSISSAUGA, Ontario, Dec. 23, 2022 (GLOBE NEWSWIRE) — Smart Employee Benefits Inc. (“SEB” or the “Company”) (TSXV: SEB) (OTCQB: SEBFF) a leader in benefits processing solutions and services today announced that Co-operators Financial Services Limited (“Co-operators”), a strategic investor in SEB, has loaned $18,000,000 to SEB (the “Loan”). The Loan is evidenced by a promissory note dated December 23, 2022 (the “Promissory Note”) issued by SEB in favour of Co-operators and bears interest at 15% per annum, with the first payment payable on February 28, 2023, with each subsequent payment to be made on the last business day of every other month thereafter, with a maturity date being the earlier of the date Co-operators makes demand and November 30, 2025. The Loan is secured over the assets of SEB. Proceeds from the Loan were used...

DENVER, Dec. 23, 2022 (GLOBE NEWSWIRE) — Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the “Company” or “Koios”) announces that further to its press release dated December 16, 2022, the British Columbia Securities  Commission (the “BCSC”) has issued a failure to file cease trade order against the Company (“FTFCTO”) which orders that general trading, whether direct or indirect, by any person, of the securities of the Company, cease, which includes trading of the shares of the Company on the Canadian Securities Exchange. The Company is diligently working with its auditors to conclude the filings at the earliest possible time. The delay in completing and filing the Company’s financial statements stems from certain valuation information that was required in connection with the Company’s...